Acute inflammatory thyromegaly following checkpoint inhibition: A new imaging entity?

Immune checkpoint blockade (CPB) utilizing such agents as ipilimumab, nivolumab, or pembrolizumab has revolutionized melanoma therapy and has seen continued utilization in numerous other malignancies in recent years. However, these agents come at the price of inflammatory immune-related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Middlebrooks, Erik H., Westbrook, Brian C., Conry, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Head and Neck
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850905/
https://www.ncbi.nlm.nih.gov/pubmed/29552247
http://dx.doi.org/10.1016/j.radcr.2017.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850905/
https://www.ncbi.nlm.nih.gov/pubmed/29552247
http://dx.doi.org/10.1016/j.radcr.2017.09.008

Ejemplares similares